TY - JOUR
T1 - Pneumococcal vaccination in adults
T2 - Recommendations, trends, and prospects
AU - Targonski, Paul V.
AU - Poland, Gregory A.
PY - 2007/6
Y1 - 2007/6
N2 - The Us Centers for Disease Control and Prevention recommends vaccination against Streptococcus pneumoniae for all people age 65 and older and also for younger people at high risk. However, experts continue to debate the efficacy of the vaccine; most observational studies found it beneficial, while clinical trials were inconclusive as a group. Although pneumococcal vaccination may or may not protect against pneumonia or death from any cause, it does significantly decrease the risk of invasive pneumococcal disease and is worthwhile for this reason.
AB - The Us Centers for Disease Control and Prevention recommends vaccination against Streptococcus pneumoniae for all people age 65 and older and also for younger people at high risk. However, experts continue to debate the efficacy of the vaccine; most observational studies found it beneficial, while clinical trials were inconclusive as a group. Although pneumococcal vaccination may or may not protect against pneumonia or death from any cause, it does significantly decrease the risk of invasive pneumococcal disease and is worthwhile for this reason.
UR - http://www.scopus.com/inward/record.url?scp=34250212173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250212173&partnerID=8YFLogxK
U2 - 10.3949/ccjm.74.6.401
DO - 10.3949/ccjm.74.6.401
M3 - Review article
C2 - 17569198
AN - SCOPUS:34250212173
SN - 0891-1150
VL - 74
SP - 401
EP - 414
JO - Cleveland Clinic Journal of Medicine
JF - Cleveland Clinic Journal of Medicine
IS - 6
ER -